Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published December 2015
  • Article
  • Info & Metrics
  • PDF
Loading

Toxicant Exposures in Smokeless Tobacco Users

Rostron et al. Page 1829

Smokeless tobacco users may have high nicotine and toxicant exposures, but studies with nationally representative data have been limited. Rostron and colleagues analyzed biomarkers of tobacco exposure for 23,684 adult participants from the National Health and Nutrition Examination Survey (NHANES). Exclusive smokeless tobacco users had higher concentrations of serum cotinine and NNAL than exclusive cigarette smokers. Smokeless tobacco users also had higher concentrations of blood lead compared with nontobacco users. The high exposure to harmful constituents among smokeless tobacco users is a continuing health issue.

Epstein-Barr Virus Hodgkin Lymphoma

Delahaye-Sourdeix et al. Page 1838

A portion of the genetic variants involved in susceptibility to Hodgkin lymphoma (HL) differ by the tumor's Epstein-Barr virus (EBV) status, particularly within the major histocompatibility complex (MHC) region. Delahaye-Sourdeix and colleagues conducted a single nucleotide polymorphism (SNP) imputation study of the MHC region, considering tumor EBV status in HL cases and controls. The authors identified a novel association between a common genetic variant rs6457715 and HL. While strongly associated with EBV-positive HL, there was little evidence for association between rs6457715 and the EBV-negative subgroup of HL. Thus, SNP rs6457715, located near the HLA-DPB1 gene, is associated with EBV-positive HL.

The AYA HOPE Cancer Comorbidity Index

Wu et al. Page 1844

Existing comorbidity indices were not developed for adolescent and young adult (AYA; 15–39 years of age) cancer survivors. Wu and colleagues assessed the impact of comorbidities on healthcare service needs and health status among AYA cancer survivors using the newly developed AYA HOPE comorbidity index in comparison with the existing indices. Of the 485 patients, 14.6% had > 2 comorbidities based on the AYA HOPE index. Prevalence of mental illness and obesity/overweight, which were not included in existing indices, were 8.2% and 5.8%, respectively. The AYA HOPE index is a more comprehensive comorbidity index for young adult cancer patients than existing indices.

Considering the Reason for a Cancer Test

Becker et al. Page 1850

Cancer screening and postsymptomatic diagnostic testing do not share the same impetus for testing but are often combined in cancer screening surveillance research. Becker and colleagues examined the error in estimated colorectal cancer screening prevalence due to the conflation of screening and diagnostic testing. The authors report that the population screening prevalence was overestimated by 23.3%, and the level of overestimation varied widely across sociodemographic groups. The highest levels of overestimation were in non-Hispanic white females and those with the highest socioeconomic vulnerability (low educational attainment, low poverty ratio, no usual source of health care and not insured). Surveillance research in cancer screening that does not consider the impetus for testing risks overestimation of screening prevalence.

  • ©2015 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 24 (12)
December 2015
Volume 24, Issue 12
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev December 1 2015 (24) (12) 1809;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev December 1 2015 (24) (12) 1809;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Toxicant Exposures in Smokeless Tobacco Users
    • Epstein-Barr Virus Hodgkin Lymphoma
    • The AYA HOPE Cancer Comorbidity Index
    • Considering the Reason for a Cancer Test
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement